Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Fish and Richardson
Moodys
Boehringer Ingelheim
Deloitte
McKesson
Cantor Fitzgerald
AstraZeneca
Queensland Health

Generated: February 23, 2018

DrugPatentWatch Database Preview

Amneal Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARMS, and what generic and branded alternatives to AMNEAL PHARMS drugs are available?

AMNEAL PHARMS has one hundred and seventy-six approved drugs.

There are twelve tentative approvals on AMNEAL PHARMS drugs.

Summary for Amneal Pharms
US Patents:0
Tradenames:135
Ingredients:130
NDAs:176

Drugs and US Patents for Amneal Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms TEMOZOLOMIDE temozolomide CAPSULE;ORAL 203691-001 May 8, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms Co SEVELAMER CARBONATE sevelamer carbonate TABLET;ORAL 207288-001 Nov 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms LEVONORGESTREL AND ETHINYL ESTRADIOL ethinyl estradiol; levonorgestrel TABLET;ORAL-28 201108-001 Feb 5, 2014 AB1 RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms Co BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 208829-004 May 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms Ny PREDNISONE prednisone TABLET;ORAL 089597-001 Oct 5, 1987 DISCN No No ➤ Sign Up ➤ Sign Up
Amneal Pharms FELBAMATE felbamate SUSPENSION;ORAL 202385-001 Dec 16, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms Ny ALPRAZOLAM alprazolam TABLET, EXTENDED RELEASE;ORAL 078387-001 May 30, 2008 AB RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms Co DOCETAXEL docetaxel INJECTABLE;INJECTION 209640-002 Jan 19, 2018 AP RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms ENTECAVIR entecavir TABLET;ORAL 206652-002 Nov 12, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Amneal Pharms MEMANTINE HYDROCHLORIDE memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205825-003 Oct 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AMNEAL PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 12/16/2011
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 9/24/2007
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Fuji
Federal Trade Commission
Colorcon
Cipla
Johnson and Johnson
Covington
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot